Thermo Fisher re­leases GeneArt prod­ucts in China

BioSpectrum (Asia) - - Supplier News -

Asia Pa­cific is pre­dicted to be the fastest grow­ing mar­ket for syn­thetic bi­ol­ogy from 2018 to 2025, driv­ing in­creased de­mand for genome edit­ing and gene syn­the­sis tech­nolo­gies. To ful­fill re­searchers’ needs, Thermo Fisher Sci­en­tific Inc., the world leader in serv­ing science, is now of­fer­ing its port­fo­lio of In­vit­ro­gen GeneArt prod­ucts and ser­vices in China.

Ac­cord­ing to the com­pany, in re­sponse to the grow­ing cus­tomer de­mand for more ef­fi­cient, re­li­able gene syn­the­sis and genome edit­ing tech­nolo­gies, the line of GeneArt prod­ucts has been launched in China. GeneArt prod­ucts will not only en­able the cus­tomers to con­tin­u­ally en­hance the un­der­stand­ing of how bi­ol­ogy works, it will also help them ac­cel­er­ate the path from plan­ning ex­per­i­ments to ex­e­cut­ing them in the lab. With the In­vit­ro­gen GeneArt prod­uct line, re­searchers in China now have ac­cess to: In­vit­ro­gen GeneArt Gene Syn­the­sis Ser­vice, GeneArt Strings DNA Frag­ments and Li­braries, and GeneArt Genome Edit­ing Tools.

Newspapers in English

Newspapers from India

© PressReader. All rights reserved.